+ Watch LMNX
on My Watchlist
The COmpany develops, manufactures and sells proprietary biological testing technologies with applications throughout the life sciences industry.
Other technologies are coming in and taking away more and more of where Luminex's performance envelope has a competitive advantage (lab geeks' "mid plex"). I see particular pressures in genetic disease testing, e.g., CF on the diagnostics front. Longer term, there is a stable business for Luminex in HLA testing (particularly the protein tests) but this is not going to provide double digit growth forever - a requirement of a company with this kind of valuation.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions